Matinas BioPharma Inc. (MTNB)
AMEX: MTNB
· Real-Time Price · USD
0.92
-0.01 (-1.22%)
At close: Jun 17, 2025, 12:09 PM
Matinas BioPharma Revenue Breakdown
| Period Ending | Dec 31, 2020 |
|---|---|
| CFF Research Grant Revenue Revenue | 125K |
| CFF Research Grant Revenue Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.86M | 1.66M | 2.14M | 2.47M | 2.22M | 1.98M | 2.84M | 2.6M | 2.71M | 2.68M | 2.82M | 2.86M | 2.74M | 2.47M | 2.26M | 2.31M | 3.15M | 3.03M | 2.36M | 2.36M | 2.26M | 2.32M | 1.89M | 1.78M | 1.79M | 2.47M | 1.57M | 1.97M | 1.96M | 2.38M | 1.44M | 1.71M | 2.12M | 1.02M | 999.8K | 977.65K | 1.32M | 1.17M | 1.34M | 1.12M | 1.18M |
| Selling, General, and Administrative Revenue Growth | +11.97% | -22.41% | -13.21% | +11.37% | +11.81% | -30.19% | +9.19% | -4.13% | +1.34% | -5.04% | -1.51% | +4.27% | +10.91% | +9.64% | -2.26% | -26.58% | +3.94% | +27.98% | +0.34% | +4.26% | -2.42% | +22.55% | +6.07% | -0.37% | -27.72% | +57.12% | -20.15% | +0.73% | -17.64% | +65.05% | -15.61% | -19.43% | +108.41% | +1.65% | +2.27% | -25.70% | +12.22% | -12.47% | +19.16% | -4.57% | n/a |
| Research and Development Revenue | 85K | 2.38M | 2.24M | 3.37M | 3.45M | 3.67M | 3.29M | 3.56M | 3.97M | 3.87M | 3.71M | 4.13M | 4.98M | 4.24M | 4.62M | 2.48M | 3.24M | 3.53M | 3.34M | 3.41M | 4.09M | 3.42M | 2.67M | 2.83M | 2.31M | 1.69M | 1.38M | 1.52M | 2.19M | 2.3M | 2.01M | 2.31M | 2.38M | 1.55M | 835.31K | 642.58K | 921.71K | 1.61M | 879.2K | 1.35M | 1.45M |
| Research and Development Revenue Growth | -96.42% | +6.12% | -33.58% | -2.18% | -5.98% | +11.23% | -7.42% | -10.35% | +2.68% | +4.31% | -10.17% | -17.11% | +17.41% | -8.25% | +86.28% | -23.47% | -8.06% | +5.68% | -2.17% | -16.56% | +19.50% | +28.02% | -5.56% | +22.21% | +36.77% | +22.68% | -9.40% | -30.56% | -4.59% | +14.18% | -13.03% | -2.92% | +54.01% | +85.33% | +29.99% | -30.28% | -42.75% | +83.11% | -35.10% | -6.47% | n/a |